Bionomics Net Income 2022-2024 | NEUP
Bionomics net income from 2022 to 2024. Net income can be defined as company's net profit or loss after all revenues, income items, and expenses have been accounted for.
Bionomics Annual Net Income
(Millions of US $) |
| 2024 |
$-15 |
| 2023 |
$-21 |
| 2022 |
$-16 |
| 2021 |
$-6 |
Bionomics Quarterly Net Income
(Millions of US $) |
| 2024-09-30 |
$-1 |
| 2024-06-30 |
|
| 2023-12-31 |
|
| 2023-09-30 |
$-5 |
| 2023-06-30 |
|
| 2022-12-31 |
|
| 2022-06-30 |
|
| 2021-06-30 |
|
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
MED-BIOMED/GENE |
$0.010B |
$0.000B |
|
Bionomics Limited is a clinical-stage biopharmaceutical developing novel, allosteric ion channel modulators designed to transform the lives of patients suffering from serious central nervous system disorders. Bionomics Limited is based in ADELAIDE, Australia.
|
